ANI Pharmaceuticals (ANIP)

[silvr_surfr]

Wow JTFM. These results are stunning. The other thing I take from these studies is their ten-year plus duration. I think this was the lesson from all of the Androgel lawsuits.

My long held belief is that testosterone is one of mother nature's most potent and fundamental "master" drugs. These results prove this out and what has kept me here through thick and thin. On the Libigel side, we also have the breast cancer story as well. As I think about it, what perfect timing to re-tell the story of testosterone for both men and women at the same time.

I'm still conflicted though. It seems like Abbvie would be in the best position to capitalize on these data. I did not know Bayer was a player either. With these results, I think there will be plenty to go around. Of course, we have to be well positioned for the female market with our patents (and those likely forthcoming) and our clinical data.

With these kinds of results, you can understand why they have been so secretive about it.

GLTA